Skip to main content
Top
Published in: International Journal of Hematology 1/2008

01-07-2008 | Original Article

Periostin and bone marrow fibrosis

Authors: Eijiro Oku, Taisuke Kanaji, Yuka Takata, Koichi Oshima, Ritsuko Seki, Satoshi Morishige, Rie Imamura, Korenori Ohtsubo, Michitoshi Hashiguchi, Koichi Osaki, Kazuaki Yakushiji, Kohji Yoshimoto, Hideaki Ogata, Hirofumi Hamada, Kenji Izuhara, Michio Sata, Takashi Okamura

Published in: International Journal of Hematology | Issue 1/2008

Login to get access

Abstract

Periostin is a secreted protein that shares structural homology with the insect axon guidance protein fasciclin 1. Periostin is expressed predominantly in collagen-rich fibrous connective tissues that are subjected to constant mechanical stresses. We have shown previously that periostin is a novel component of subepithelial fibrosis in bronchial asthma. Here, we investigated the relationship between periostin and bone marrow (BM) fibrosis. Periostin was expressed in the stroma and stromal cells of BM fibrosis specimens and to a great extent its expression levels correlated closely to the grade of fibrosis, as estimated by silver staining. However, in the present study, we found no relationship between plasma periostin levels and the extent of BM fibrosis. We also demonstrated that periostin is secreted by human BM hTERT stromal cells and that its secretion is enhanced by TGF-β, a cytokine produced by clonal proliferation of megakaryocytes and/or monocytes. These results indicate that periostin is a component of BM fibrosis and that it may play a role in the disease progression.
Literature
1.
go back to reference Kuter DJ, Bain B, Mufti G, et al. Bone marrow fibrosis: pathophysiology and clinical significance of increased bone marrow stromal fibres. Br J Haematol. 2007;139:351–62.CrossRefPubMed Kuter DJ, Bain B, Mufti G, et al. Bone marrow fibrosis: pathophysiology and clinical significance of increased bone marrow stromal fibres. Br J Haematol. 2007;139:351–62.CrossRefPubMed
2.
go back to reference Thiele J, Kvasnicka HM. Grade of bone marrow fibrosis is associated with relevant hematological findings-a clinicopathological study on 865 patients with chronic idiopathic myelofibrosis. Ann Hematol. 2006;85:226–32.CrossRefPubMed Thiele J, Kvasnicka HM. Grade of bone marrow fibrosis is associated with relevant hematological findings-a clinicopathological study on 865 patients with chronic idiopathic myelofibrosis. Ann Hematol. 2006;85:226–32.CrossRefPubMed
3.
go back to reference Tefferi A, Thiele J, Orazi A, et al. Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel. Blood. 2007;110:1092–7.CrossRefPubMed Tefferi A, Thiele J, Orazi A, et al. Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel. Blood. 2007;110:1092–7.CrossRefPubMed
4.
go back to reference Martyre MC, Romquin N, Le Bousse-Kerdiles MC, et al. Transforming growth factor-beta and megakaryocytes in the pathogenesis of idiopathic myelofibrosis. Br J Haematol. 1994;88:9–16.CrossRefPubMed Martyre MC, Romquin N, Le Bousse-Kerdiles MC, et al. Transforming growth factor-beta and megakaryocytes in the pathogenesis of idiopathic myelofibrosis. Br J Haematol. 1994;88:9–16.CrossRefPubMed
5.
go back to reference Rameshwar P, Denny TN, Stein D, et al. Monocyte adhesion in patients with bone marrow fibrosis is required for the production of fibrogenic cytokines. Potential role for interleukin-1 and TGF-beta. J Immunol. 1994;153:2819–30.PubMed Rameshwar P, Denny TN, Stein D, et al. Monocyte adhesion in patients with bone marrow fibrosis is required for the production of fibrogenic cytokines. Potential role for interleukin-1 and TGF-beta. J Immunol. 1994;153:2819–30.PubMed
6.
go back to reference Chagraoui H, Komura E, Tulliez M, et al. Prominent role of TGF-beta 1 in thrombopoietin-induced myelofibrosis in mice. Blood. 2002;100:3495–503.CrossRefPubMed Chagraoui H, Komura E, Tulliez M, et al. Prominent role of TGF-beta 1 in thrombopoietin-induced myelofibrosis in mice. Blood. 2002;100:3495–503.CrossRefPubMed
7.
go back to reference Wang JC, Hemavathy K, Charles W, et al. Osteosclerosis in idiopathic myelofibrosis is related to the overproduction of osteoprotegerin (OPG). Exp Hematol. 2004;32:905–10.CrossRefPubMed Wang JC, Hemavathy K, Charles W, et al. Osteosclerosis in idiopathic myelofibrosis is related to the overproduction of osteoprotegerin (OPG). Exp Hematol. 2004;32:905–10.CrossRefPubMed
8.
go back to reference Kakumitsu H, Kamezaki K, Shimoda K, et al. Transgenic mice overexpressing murine thrombopoietin develop myelofibrosis and osteosclerosis. Leuk Res. 2005;29:761–9.CrossRefPubMed Kakumitsu H, Kamezaki K, Shimoda K, et al. Transgenic mice overexpressing murine thrombopoietin develop myelofibrosis and osteosclerosis. Leuk Res. 2005;29:761–9.CrossRefPubMed
9.
go back to reference Okamura T, Kinukawa N, Niho Y, et al. Primary chronic myelofibrosis: clinical and prognostic evaluation in 336 Japanese patients. Int J Hematol. 2001;73:194–8.CrossRefPubMed Okamura T, Kinukawa N, Niho Y, et al. Primary chronic myelofibrosis: clinical and prognostic evaluation in 336 Japanese patients. Int J Hematol. 2001;73:194–8.CrossRefPubMed
10.
go back to reference Horiuchi K, Amizuka N, Takeshita S, et al. Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta. J Bone Miner Res. 1999;14:1239–49.CrossRefPubMed Horiuchi K, Amizuka N, Takeshita S, et al. Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta. J Bone Miner Res. 1999;14:1239–49.CrossRefPubMed
11.
go back to reference Sasaki H, Lo KM, Chen LB, et al. Expression of Periostin, homologous with an insect cell adhesion molecule, as a prognostic marker in non-small cell lung cancers. Jpn J Cancer Res. 2001;92:869–73.CrossRefPubMed Sasaki H, Lo KM, Chen LB, et al. Expression of Periostin, homologous with an insect cell adhesion molecule, as a prognostic marker in non-small cell lung cancers. Jpn J Cancer Res. 2001;92:869–73.CrossRefPubMed
12.
go back to reference Sasaki H, Dai M, Auclair D, et al. Serum level of the periostin, a homologue of an insect cell adhesion molecule, in thymoma patients. Cancer Lett. 2001;172:37–42.CrossRefPubMed Sasaki H, Dai M, Auclair D, et al. Serum level of the periostin, a homologue of an insect cell adhesion molecule, in thymoma patients. Cancer Lett. 2001;172:37–42.CrossRefPubMed
13.
go back to reference Sasaki H, Dai M, Auclair D, et al. Serum level of the periostin, a homologue of an insect cell adhesion molecule, as a prognostic marker in nonsmall cell lung carcinomas. Cancer. 2001;92:843–8.CrossRefPubMed Sasaki H, Dai M, Auclair D, et al. Serum level of the periostin, a homologue of an insect cell adhesion molecule, as a prognostic marker in nonsmall cell lung carcinomas. Cancer. 2001;92:843–8.CrossRefPubMed
14.
go back to reference Sasaki H, Sato Y, Kondo S, et al. Expression of the periostin mRNA level in neuroblastoma. J Pediatr Surg. 2002;37:1293–7.CrossRefPubMed Sasaki H, Sato Y, Kondo S, et al. Expression of the periostin mRNA level in neuroblastoma. J Pediatr Surg. 2002;37:1293–7.CrossRefPubMed
15.
go back to reference Li JS, Sun GW, Wei XY, et al. Expression of periostin and its clinicopathological relevance in gastric cancer. World J Gastroenterol. 2007;13:5261–6.CrossRefPubMedPubMedCentral Li JS, Sun GW, Wei XY, et al. Expression of periostin and its clinicopathological relevance in gastric cancer. World J Gastroenterol. 2007;13:5261–6.CrossRefPubMedPubMedCentral
16.
go back to reference Gillan L, Matei D, Fishman DA, et al. Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility. Cancer Res. 2002;62:5358–64.PubMed Gillan L, Matei D, Fishman DA, et al. Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility. Cancer Res. 2002;62:5358–64.PubMed
17.
go back to reference Kudo Y, Ogawa I, Kitajima S, et al. Periostin promotes invasion and anchorage-independent growth in the metastatic process of head and neck cancer. Cancer Res. 2006;66:6928–35.CrossRefPubMed Kudo Y, Ogawa I, Kitajima S, et al. Periostin promotes invasion and anchorage-independent growth in the metastatic process of head and neck cancer. Cancer Res. 2006;66:6928–35.CrossRefPubMed
18.
go back to reference Kudo Y, Siriwardena BS, Hatano H, et al. Periostin: novel diagnostic and therapeutic target for cancer. Histol Histopathol. 2007;22:1167–74.PubMed Kudo Y, Siriwardena BS, Hatano H, et al. Periostin: novel diagnostic and therapeutic target for cancer. Histol Histopathol. 2007;22:1167–74.PubMed
19.
go back to reference Oka T, Xu J, Kaiser RA, et al. Genetic manipulation of periostin expression reveals a role in cardiac hypertrophy and ventricular remodeling. Circ Res. 2007;101:313–21.CrossRefPubMedPubMedCentral Oka T, Xu J, Kaiser RA, et al. Genetic manipulation of periostin expression reveals a role in cardiac hypertrophy and ventricular remodeling. Circ Res. 2007;101:313–21.CrossRefPubMedPubMedCentral
20.
go back to reference Kuhn B, del Monte F, Hajjar RJ, et al. Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair. Nat Med. 2007;13:962–9.CrossRefPubMed Kuhn B, del Monte F, Hajjar RJ, et al. Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair. Nat Med. 2007;13:962–9.CrossRefPubMed
21.
go back to reference Yoshiba N, Yoshiba K, Hosoya A, et al. Association of TIMP-2 with extracellular matrix exposed to mechanical stress and its co-distribution with periostin during mouse mandible development. Cell Tissue Res. 2007;330:133–45.CrossRefPubMed Yoshiba N, Yoshiba K, Hosoya A, et al. Association of TIMP-2 with extracellular matrix exposed to mechanical stress and its co-distribution with periostin during mouse mandible development. Cell Tissue Res. 2007;330:133–45.CrossRefPubMed
22.
go back to reference Blumer MJ, Schwarzer C, Perez MT, et al. Identification and location of bone-forming cells within cartilage canals on their course into the secondary ossification centre. J Anat. 2006;208:695–707.CrossRefPubMedPubMedCentral Blumer MJ, Schwarzer C, Perez MT, et al. Identification and location of bone-forming cells within cartilage canals on their course into the secondary ossification centre. J Anat. 2006;208:695–707.CrossRefPubMedPubMedCentral
23.
go back to reference Takayama G, Arima K, Kanaji T, et al. Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals. J Allergy Clin Immunol. 2006;118:98–104.CrossRefPubMed Takayama G, Arima K, Kanaji T, et al. Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals. J Allergy Clin Immunol. 2006;118:98–104.CrossRefPubMed
24.
go back to reference Norris RA, Damon B, Mironov V, et al. Periostin regulates collagen fibrillogenesis and the biomechanical properties of connective tissues. J Cell Biochem. 2007;101:695–711.CrossRefPubMedPubMedCentral Norris RA, Damon B, Mironov V, et al. Periostin regulates collagen fibrillogenesis and the biomechanical properties of connective tissues. J Cell Biochem. 2007;101:695–711.CrossRefPubMedPubMedCentral
25.
go back to reference Thiele J, Kvasnicka HM, Facchetti F, et al. European consensus on grading bone marrow fibrosis and assessment of cellularity. Haematologica. 2005;90:1128–32.PubMed Thiele J, Kvasnicka HM, Facchetti F, et al. European consensus on grading bone marrow fibrosis and assessment of cellularity. Haematologica. 2005;90:1128–32.PubMed
26.
go back to reference Wilkins BS, Erber WN, Bareford D, et al. Bone marrow pathology in essential thrombocythemia: inter-observer reliability and utility for identifying disease subtypes. Blood. 2008;111:60–70.CrossRefPubMed Wilkins BS, Erber WN, Bareford D, et al. Bone marrow pathology in essential thrombocythemia: inter-observer reliability and utility for identifying disease subtypes. Blood. 2008;111:60–70.CrossRefPubMed
27.
go back to reference Chelloul N, Briere J, Laval-Jeantet M, et al. Prognosis of myeloid metaplasia with myelofibrosis. Biomedicine. 1976;24:272–80.PubMed Chelloul N, Briere J, Laval-Jeantet M, et al. Prognosis of myeloid metaplasia with myelofibrosis. Biomedicine. 1976;24:272–80.PubMed
28.
go back to reference Chichibu K, Matsuura T, Shichijo S, et al. Assay of serum hyaluronic acid in clinical application. Clin Chim Acta. 1989;181:317–23.CrossRefPubMed Chichibu K, Matsuura T, Shichijo S, et al. Assay of serum hyaluronic acid in clinical application. Clin Chim Acta. 1989;181:317–23.CrossRefPubMed
29.
go back to reference Yamada S, Suou T, Kawasaki H, et al. Clinical significance of serum 7S collagen in various liver diseases. Clin Biochem. 1992;25:467–70.CrossRefPubMed Yamada S, Suou T, Kawasaki H, et al. Clinical significance of serum 7S collagen in various liver diseases. Clin Biochem. 1992;25:467–70.CrossRefPubMed
30.
go back to reference Kawano Y, Kobune M, Yamaguchi M, et al. Ex vivo expansion of human umbilical cord hematopoietic progenitor cells using a coculture system with human telomerase catalytic subunit (hTERT)-transfected human stromal cells. Blood. 2003;101:532–40.CrossRefPubMed Kawano Y, Kobune M, Yamaguchi M, et al. Ex vivo expansion of human umbilical cord hematopoietic progenitor cells using a coculture system with human telomerase catalytic subunit (hTERT)-transfected human stromal cells. Blood. 2003;101:532–40.CrossRefPubMed
31.
go back to reference Baxter EJ, Scott LM, Campbell PJ, et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet. 2005;365:1054–61.CrossRefPubMed Baxter EJ, Scott LM, Campbell PJ, et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet. 2005;365:1054–61.CrossRefPubMed
32.
go back to reference Tefferi A. Primary myelofibrosis and its paraneoplastic stromal effects. Haematologica. 2007;92:577–9.CrossRefPubMed Tefferi A. Primary myelofibrosis and its paraneoplastic stromal effects. Haematologica. 2007;92:577–9.CrossRefPubMed
33.
go back to reference Tai IT, Dai M, Chen LB. Periostin induction in tumor cell line explants and inhibition of in vitro cell growth by anti-periostin antibodies. Carcinogenesis. 2005;26:908–15.CrossRefPubMed Tai IT, Dai M, Chen LB. Periostin induction in tumor cell line explants and inhibition of in vitro cell growth by anti-periostin antibodies. Carcinogenesis. 2005;26:908–15.CrossRefPubMed
34.
go back to reference Bao S, Ouyang G, Bai X, et al. Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway. Cancer Cell. 2004;5:329–39.CrossRefPubMed Bao S, Ouyang G, Bai X, et al. Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway. Cancer Cell. 2004;5:329–39.CrossRefPubMed
35.
go back to reference Lagergren A, Mansson R, Zetterblad J, et al. The Cxcl12, periostin, and Ccl9 genes are direct targets for early B-cell factor in OP-9 stroma cells. J Biol Chem. 2007;282:14454–62.CrossRefPubMed Lagergren A, Mansson R, Zetterblad J, et al. The Cxcl12, periostin, and Ccl9 genes are direct targets for early B-cell factor in OP-9 stroma cells. J Biol Chem. 2007;282:14454–62.CrossRefPubMed
Metadata
Title
Periostin and bone marrow fibrosis
Authors
Eijiro Oku
Taisuke Kanaji
Yuka Takata
Koichi Oshima
Ritsuko Seki
Satoshi Morishige
Rie Imamura
Korenori Ohtsubo
Michitoshi Hashiguchi
Koichi Osaki
Kazuaki Yakushiji
Kohji Yoshimoto
Hideaki Ogata
Hirofumi Hamada
Kenji Izuhara
Michio Sata
Takashi Okamura
Publication date
01-07-2008
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 1/2008
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-008-0095-2

Other articles of this Issue 1/2008

International Journal of Hematology 1/2008 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine